Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia

Abstract Background Chemotherapy is still the standard regimen for treating acute myeloid leukemia (AML) and its disappointing efficacy requires the urgent need for new therapeutic targets. It is well known that immune response plays an increasingly significant role in the pathogenesis of AML. Metho...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuyan Wu, Mingying Li, Guangqiang Meng, Yuechan Ma, Jingjing Ye, Tao Sun, Chunyan Ji
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-09-01
Edice:	Cancer Medicine
Témata:	acute myeloid leukemia immune checkpoint PD1 prognosis single nucleotide polymorphism susceptibility
On-line přístup:	https://doi.org/10.1002/cam4.6468
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!